[1]
“POSSIBILITIES OF USING RUXOLITINIB TO IMPROVE THE RESULTS OF allo-HSCT (LITERATURE REVIEW)”, Вопр. онкол., vol. 65, no. 3, pp. 330–336, Mar. 2019, doi: 10.37469/0507-3758-2019-65-3-330-336.